All ABBV Content

AbbVie (ABBV) Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions

AbbVie (NYSE: ABBV) FY 2026 Other Release

March 19, 20261 min read

AbbVie (ABBV) AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults

AbbVie (NYSE: ABBV) FY 2026 Other Release

March 9, 20261 min read

AbbVie (ABBV) Sec Form 8K

AbbVie (NYSE: ABBV) Sec Form 8K

March 6, 20261 min read

AbbVie (ABBV) Allergan Aesthetics Highlights Medical Weight Loss (Mwl) Data And The Changing Profile Of Patients

AbbVie (NYSE: ABBV) FY 2026 Other Release

March 4, 20261 min read

AbbVie (ABBV) Leerink Partners Global Healthcare Conference

AbbVie (NYSE: ABBV) FY 2026 Corporate Conference

March 3, 20261 min read

AbbVie (ABBV) AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn’s Disease

AbbVie (NYSE: ABBV) FY 2026 Other Release

March 2, 20261 min read

AbbVie (ABBV) Sec Form 8K

AbbVie (NYSE: ABBV) Sec Form 8K

February 28, 20261 min read

AbbVie (ABBV) TD Cowen 46th Annual Health Care Conference

AbbVie (NYSE: ABBV) FY 2026 Corporate Conference

February 24, 20261 min read

AbbVie (ABBV) AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

AbbVie (NYSE: ABBV) FY 2026 Other Release

February 23, 20261 min read

AbbVie (ABBV) Sec Form 10K

AbbVie (NYSE: ABBV) Sec Form 10K

February 22, 20261 min read